Drug Import Fairness Act of 1999

Telemedicine (HR 312, HR 3240, HR 4771, S 2505); Clinical Laboratory Improvement Amendments of 1999 (HR 528); genetic testing and confidentiality (HR 1507, HR 1941, HR 2404, HR 2455, HR 2470, S 573, S 578, S 881, HR 293, HR 306, HR 2457, S 543, S 1322, HR 2878, HR 4049, HR 4585); forensic pathology (HR 1915, HR 2340, S 1196, HR 2810, HR 3087, HR 3233, HR3375, S 1700, S 1981); bioterrorism; Pap smears (HR4330, HR 4571); Medicare issues pertaining to the laboratory; Allied Health Project Grants program (HR 4577); Medical liability reform (HR2242, HR 4577); graduate medical education (HR 1222, HR 1224, HR 1645, HR 1785, HR 2771, HR 4239, S 210, S541, S 1023, S 1024, S 1025, S 1631, S 2394); Patient access to care (HR 2723, HR 2824, HR 2926, HR 2990, HR 3146, S 6, S 326, HR 4577); Issues pertaining to microbiology, blood, diagnostic immunology, cytology, clinical chemistry, forensic pathology); telemedicine (HR 1344, HR 4771, S 2505); other diagnostic screening tests (HR 1285, HR 2930, S 1641, HR 1861, S 1044); rural health (HR 1344, HR 4677, S 1864, S 2735); patient safety (HR 3672, S 2038, S 2378, S 2738, S 2743); and genetics (HR 293, HR 306, HR 2457, HR 2878, S 543, S 1322).